• Sign up
  • ‎What is Shvoong?‎
  • Sign In
    Sign In
    Remember my username Forgot your password?

Summaries and Short Reviews

.

Shvoong Home>Medicine & Health>Should an Institution That Has Commercial Rights in a New Drug or Device Be Allowed to Evaluate the Summary

.

Should an Institution That Has Commercial Rights in a New Drug or Device Be Allowed to Evaluate the

Book Abstract by: PLoS     

Original Authors: McKinney Ross; Korn David
Background to the debate: In the United States, the passage of the BayhDole Act in 1980 encouraged universities to license
inventions for commercial development. Although this financial incentive can stimulate academic researchers to discover new drugs and devices, there is concern that the possibility of monetary reward could distort investigators'' objectivity.
Published: January 25, 2005
Please Rate this Review : 1 2 3 4 5

Bookmark & share this post

.